Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study. Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Eraksoy M, et al. Mult Scler. 2012 Mar; 18(3):314-21. Epub 2011 Aug 30. PMID: 21878455. Abstract CommentRecommendBookmarkWatch